Liquidia (LQDA) Shareholder's Equity Growth (5y) (2024 - 2026)
Liquidia (LQDA) Shareholder's Equity Growth (5y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - |
| 10 | Liquidia | 6.98 Bn | 6.76 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.53% |
| Dec 31, 2025 | -8.84% |
| Sep 30, 2025 | -19.51% |
| Jun 30, 2025 | 11.36% |
| Mar 31, 2025 | 17.95% |
| Dec 31, 2024 | 17.83% |